209 related articles for article (PubMed ID: 27090770)
1. Short-Term Outcomes of Patent Ductus Arteriosus Closure With New Occlutech® Duct Occluder: A Multicenter Study.
Dedeoglu R; Bilici M; Demir F; Demir F; Acar OÇ; Hallioglu O; Pac A; Kiziltas A; Karabel D; Kula S; Cimen D; Baspinar O; Atik SU; Saltik IL
J Interv Cardiol; 2016 Jun; 29(3):325-31. PubMed ID: 27090770
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
3. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
4. The new occlutech duct occluder: immediate results, procedural challenges, and short-term follow-up.
Kudumula V; Taliotis D; Duke C
J Invasive Cardiol; 2015 May; 27(5):250-7. PubMed ID: 25929302
[TBL] [Abstract][Full Text] [Related]
5. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
6. The new Occlutech® PDA occluder: Initial human experience.
Abdelbasit MA; Alwi M; Kandavello G; Che Mood M; Samion H; Hijazi ZM
Catheter Cardiovasc Interv; 2015 Jul; 86(1):94-9. PubMed ID: 25675888
[TBL] [Abstract][Full Text] [Related]
7. Does a Change in Device Design Alter Device Size Selection? A Comparison of Conventional and Occlutech Duct Occluder Designs.
Subramanian A; Paraswanath BA; Govind Auradkar ; Mahimarangaiah J
Heart Lung Circ; 2022 Dec; 31(12):1677-1684. PubMed ID: 36089464
[TBL] [Abstract][Full Text] [Related]
8. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
9. Cardi-O-Fix duct occluder versus Amplatzer duct occluder for closure of patent ductus arteriosus.
Celebi A; Demir IH; Saritaş T; Dedeoğlu R; Yucel IK; Demir F; Erdem A
Catheter Cardiovasc Interv; 2013 Nov; 82(6):961-7. PubMed ID: 23592558
[TBL] [Abstract][Full Text] [Related]
10. Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience.
Karagöz T; Akin A; Ertuğrul I; Aykan HH; Alehan D; Ozer S; Ozkutlu S
Acta Cardiol; 2012 Dec; 67(6):675-80. PubMed ID: 23393938
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of patent ductus arteriosus using the AMPLATZER™ duct occluder II (ADO II).
Gruenstein DH; Ebeid M; Radtke W; Moore P; Holzer R; Justino H
Catheter Cardiovasc Interv; 2017 May; 89(6):1118-1128. PubMed ID: 28258658
[TBL] [Abstract][Full Text] [Related]
12. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study.
Sungur M; Karakurt C; Ozbarlas N; Baspinar O
Catheter Cardiovasc Interv; 2013 Aug; 82(2):245-52. PubMed ID: 23460349
[TBL] [Abstract][Full Text] [Related]
13. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.
P S; Jose J; George OK
Indian Heart J; 2018; 70(2):308-315. PubMed ID: 29716712
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
15. Trans-catheter closure of patent ductus arteriosus-What is the best device?
Ghasemi A; Pandya S; Reddy SV; Turner DR; Du W; Navabi MA; Mirzaaghayan MR; Kiani A; Sloan K; Forbes TJ
Catheter Cardiovasc Interv; 2010 Nov; 76(5):687-95. PubMed ID: 20815044
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of the patent ductus arteriosus using the Nit-Occlud PDA-R (reverse) device: initial experience reporting immediate and short-term results.
Peirone A; Diaz J; Contreras A; Banille E; Cabrera M; Spillmann A; Bueno N; Juaneda E
J Invasive Cardiol; 2011 Dec; 23(12):513-6. PubMed ID: 22147399
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the feasibility, safety, and efficacy of Cocoon Duct Occluder for transcatheter closure of large patent ductus arteriosus: A single-center study with short- and medium-term follow-up results.
Sinha SK; Razi M; Pandey RN; Kumar P; Krishna V; Jha MJ; Mishra V; Asif M; Abdali N; Tewari P; Thakur R; Pandey U; Varma CM
Anatol J Cardiol; 2017 Nov; 18(5):321-327. PubMed ID: 29145233
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus.
Jin M; Liang YM; Wang XF; Guo BJ; Zheng K; Gu Y; Lyu ZY
Chin Med J (Engl); 2015 Sep; 128(17):2284-9. PubMed ID: 26315073
[TBL] [Abstract][Full Text] [Related]
19. Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA; Trentacoste L; Rivarola M; Barbosa JD; Lucini V; Peirone A; Spillman A
Catheter Cardiovasc Interv; 2015 Aug; 86(2):258-63. PubMed ID: 23460494
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).
Kanabar K; Bootla D; Kaur N; Pruthvi CR; Krishnappa D; Santosh K; Guleria V; Rohit MK
Indian Heart J; 2020; 72(2):107-112. PubMed ID: 32534682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
